Victor Greiff

Victor Greiff

Universitetet i Oslo

H-index: 33

Europe-Norway

About Victor Greiff

Victor Greiff, With an exceptional h-index of 33 and a recent h-index of 32 (since 2020), a distinguished researcher at Universitetet i Oslo, specializes in the field of Adaptive Immunity, Computational Biology, Artificial Intelligence.

His recent articles reflect a diverse array of research interests and contributions to the field:

Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence (vol 14, 1265044, 2023)

Baselining the Buzz. Trastuzumab-HER2 Affinity, and Beyond!

Predicting the immune escape of SARS-CoV-2 neutralizing antibodies upon mutation

Corrigendum: Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence

Author Correction: The dengue-specific immune response and antibody identification with machine learning

NKG2A discriminates natural killer cells with a suppressed phenotype in pediatric acute leukemia

Publisher Correction: Adaptive immune receptor repertoire analysis

Improving generalization of machine learning-identified biomarkers using causal modelling with examples from immune receptor diagnostics

Victor Greiff Information

University

Position

Associate Professor Laboratory for Computational and Systems Immunology

Citations(all)

3615

Citations(since 2020)

3308

Cited By

1043

hIndex(all)

33

hIndex(since 2020)

32

i10Index(all)

57

i10Index(since 2020)

56

Email

University Profile Page

Universitetet i Oslo

Google Scholar

View Google Scholar Profile

Victor Greiff Skills & Research Interests

Adaptive Immunity

Computational Biology

Artificial Intelligence

Top articles of Victor Greiff

Title

Journal

Author(s)

Publication Date

Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence (vol 14, 1265044, 2023)

Frontiers in Immunology

Lorenzo Federico

Brandon Malone

Simen Tennøe

Viktoriia Chaban

Julie Røkke Osen

...

2023

Baselining the Buzz. Trastuzumab-HER2 Affinity, and Beyond!

bioRxiv

Lewis Chinery

Alissa M Hummer

Brij Bhushan Mehta

Rahmad Akbar

Puneet Rawat

...

2024

Predicting the immune escape of SARS-CoV-2 neutralizing antibodies upon mutation

Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease

Divya Sharma

Puneet Rawat

Victor Greiff

Vani Janakiraman

M Michael Gromiha

2024/2/1

Corrigendum: Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence

Frontiers in Immunology

Lorenzo Federico

Brandon Malone

Simen Tennøe

Viktoriia Chaban

Julie Røkke Osen

...

2024/2/21

Author Correction: The dengue-specific immune response and antibody identification with machine learning

npj Vaccines

Eriberto Noel Natali

Alexander Horst

Patrick Meier

Victor Greiff

Mario Nuvolone

...

2024

NKG2A discriminates natural killer cells with a suppressed phenotype in pediatric acute leukemia

Journal of Leukocyte Biology

Aina Ulvmoen

Victor Greiff

Anne G Bechensteen

Marit Inngjerdingen

2024/2

Publisher Correction: Adaptive immune receptor repertoire analysis

Vanessa Mhanna

Habib Bashour

Khang Lê Quý

Pierre Barennes

Puneet Rawat

...

2024/2/16

Improving generalization of machine learning-identified biomarkers using causal modelling with examples from immune receptor diagnostics

Milena Pavlović

Ghadi S Al Hajj

Chakravarthi Kanduri

Johan Pensar

Mollie E Wood

...

2024/1

Adaptive immune receptor repertoire analysis

Vanessa Mhanna

Habib Bashour

Khang Lê Quý

Pierre Barennes

Puneet Rawat

...

2024/1/25

Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants

Maria Iacobescu

Cristina Pop

Alina Uifălean

Cristina Mogoşan

Diana Cenariu

...

2024/2/16

Author Correction: Insights into next generation sequencing guided antibody selection strategies

Scientific reports

M Frank Erasmus

Fortunato Ferrara

Sara D’Angelo

Laura Spector

Camila Leal-Lopes

...

2024

The dengue-specific immune response and antibody identification with machine learning

npj Vaccines

Eriberto Noel Natali

Alexander Horst

Patrick Meier

Victor Greiff

Mario Nuvolone

...

2024/1/20

ExpoSeq: simplified analysis of high-throughput sequencing data from antibody discovery campaigns

Bioinformatics Advances

Christoffer V Sørensen

Nils Hofmann

Puneet Rawat

Frederik V Sørensen

Anne Ljungars

...

2024/2/10

Systematic evaluation of B-cell clonal family inference approaches

BMC immunology

Daria Balashova

Barbera DC van Schaik

Maria Stratigopoulou

Jeroen EJ Guikema

Tom G Caniels

...

2024/12

Assessing AF2's ability to predict structural ensembles of proteins

bioRxiv

Jakob R Riccabona

Fabian C Spoendlin

Anna-Lena M Fischer

Johannes R Loeffler

Patrick K Quoika

...

2024

Preclinical Evaluation of an Anti-CD41 CAR T Cell in Acute Megakaryoblastic Leukemia on in Vitro and In Vivo Models

Transplantation and Cellular Therapy

Adrian Bogdan Tigu

Catalin Constantinescu

Patric Teodorescu

David Kegyes

Raluca Munteanu

...

2024/2/1

The evolutionary and functional significance of germline immunoglobulin gene variation

Matt Pennell

Oscar L Rodriguez

Corey T Watson

Victor Greiff

2022/12/2

Simulation of adaptive immune receptors and repertoires with complex immune information to guide the development and benchmarking of AIRR machine learning

bioRxiv

Maria Chernigovskaya

Milena Pavlović

Chakravarthi Kanduri

Sofie Gielis

Philippe A Robert

...

2023/10/23

Best practices for machine learning in antibody discovery and development

arXiv preprint arXiv:2312.08470

Leonard Wossnig

Norbert Furtmann

Andrew Buchanan

Sandeep Kumar

Victor Greiff

2023/12/13

MDS cells maturation induced by ATRA differentiating agent in myelodysplastic syndromes.

Studia Universitatis Babes-Bolyai, Historia Artium

Diana Cenariu

Adrian Bogdan Tigu

David Kegyes

Mareike Peters

Jon Thor Bergthorsson

...

2023/7/1

See List of Professors in Victor Greiff University(Universitetet i Oslo)